Innovative cTWAS Tool Enhances Identification of Disease-Causing Genes
February 1, 2024Researchers at the University of Chicago have introduced a novel statistical tool called causal-transcriptome-wide association studies (cTWAS), designed to enhance the identification of disease-causing genes and variants. cTWAS combines data from genome-wide association studies (GWAS) with gene expression predictions, utilizing advanced statistical techniques to reduce false positives and address confounding factors. Unlike traditional methods focusing on individual genes, cTWAS considers surrounding genes and variants, improving the likelihood of identifying the actual causal gene. The tool aims to overcome challenges in transitioning from GWAS association to causality, providing a valuable resource for connecting genetic variations to phenotypes.
Key Points:
- Researchers at the University of Chicago have developed a statistical tool, cTWAS, to enhance the identification of disease-causing genes and variants.
- cTWAS combines data from genome-wide association studies (GWAS) with gene expression predictions, utilizing advanced statistical techniques to reduce false positives.
- Traditional methods may generate false positives due to confounding factors, and cTWAS addresses this challenge by considering surrounding genes and variants.
- The tool aims to facilitate the transition from GWAS association to causality, offering an improved approach for connecting genetic variations to phenotypes.
- cTWAS demonstrated utility in studying the genetics of LDL cholesterol levels, identifying 35 putative causal genes, including previously unreported candidates.
- The cTWAS software is available for download from the researchers’ lab website.
Implications: The introduction of the cTWAS tool represents a significant advancement in the field of genetic research, particularly in the identification of disease-causing genes and variants. By combining GWAS data with gene expression predictions and addressing confounding factors, cTWAS provides a more reliable approach to connect genetic variations to phenotypes. The tool’s utility in studying the genetics of LDL cholesterol levels showcases its potential for uncovering previously unreported causal genes. Researchers and clinicians can leverage cTWAS to enhance the accuracy of genetic analyses, ultimately contributing to a better understanding of the genetic basis of various diseases and facilitating the development of targeted interventions.
Reference
Zhao, S., Crouse, W., Qian, S., Luo, K., Stephens, M., & He, X. (2024). Adjusting for genetic confounders in transcriptome-wide association studies improves discovery of risk genes of complex traits. Nature Genetics, 1-12.
